<DOC>
	<DOCNO>NCT00618709</DOCNO>
	<brief_summary>The purpose research evaluate safety pharmacokinetic profile single dose ATX-101</brief_summary>
	<brief_title>Dose-Escalation Safety Pharmacokinetic Study ATX-101</brief_title>
	<detailed_description>This single center , open-label , dose-escalation study subject receive 4 different dosage concentration ( 3 dose paradigm ) ATX-101 single dosing session .</detailed_description>
	<criteria>Healthy male nonpregnant female Age 18 65 Sufficient submental fat injection Signed informed consent Prior intervention chin neck area History presence drug alcohol abuse Treatment investigational agent within 30 day dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>